135 related articles for article (PubMed ID: 6272284)
1. Diphtheria toxin fragment forms large pores in phospholipid bilayer membranes.
Kagan BL; Finkelstein A; Colombini M
Proc Natl Acad Sci U S A; 1981 Aug; 78(8):4950-4. PubMed ID: 6272284
[TBL] [Abstract][Full Text] [Related]
2. Prospects of Using Protein Engineering for Selective Drug Delivery into a Specific Compartment of Target Cells.
Rosenkranz AA; Slastnikova TA
Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986848
[TBL] [Abstract][Full Text] [Related]
3. Targeting the Inside of Cells with Biologicals: Toxin Routes in a Therapeutic Context.
Ruschig M; Marschall ALJ
BioDrugs; 2023 Mar; 37(2):181-203. PubMed ID: 36729328
[TBL] [Abstract][Full Text] [Related]
4. Requirement of Peptidyl-Prolyl Cis/Trans isomerases and chaperones for cellular uptake of bacterial AB-type toxins.
Ernst K
Front Cell Infect Microbiol; 2022; 12():938015. PubMed ID: 35992160
[TBL] [Abstract][Full Text] [Related]
5. Interactions between the Re-Emerging Pathogen
Ott L; Möller J; Burkovski A
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328715
[No Abstract] [Full Text] [Related]
6. The geometry of diphtheria toxoid CRM197 channel assessed by thiazolium salts and nonelectrolytes.
Shatursky OY; Manoilov KY; Gorbatiuk OB; Usenko MO; Zhukova DA; Vovk AI; Kobzar OL; Trikash IO; Borisova TA; Kolibo DV; Komisarenko SV
Biophys J; 2021 Jun; 120(12):2577-2591. PubMed ID: 33940022
[TBL] [Abstract][Full Text] [Related]
7. Second-generation IL-2 receptor-targeted diphtheria fusion toxin exhibits antitumor activity and synergy with anti-PD-1 in melanoma.
Cheung LS; Fu J; Kumar P; Kumar A; Urbanowski ME; Ihms EA; Parveen S; Bullen CK; Patrick GJ; Harrison R; Murphy JR; Pardoll DM; Bishai WR
Proc Natl Acad Sci U S A; 2019 Feb; 116(8):3100-3105. PubMed ID: 30718426
[TBL] [Abstract][Full Text] [Related]
8. Topography of the TH5 Segment in the Diphtheria Toxin T-Domain Channel.
Kienker PK; Wu Z; Finkelstein A
J Membr Biol; 2016 Apr; 249(1-2):181-96. PubMed ID: 26645703
[TBL] [Abstract][Full Text] [Related]
9. Engineered nanoparticles mimicking cell membranes for toxin neutralization.
Fang RH; Luk BT; Hu CM; Zhang L
Adv Drug Deliv Rev; 2015 Aug; 90():69-80. PubMed ID: 25868452
[TBL] [Abstract][Full Text] [Related]
10. Human trypanolytic factor APOL1 forms pH-gated cation-selective channels in planar lipid bilayers: relevance to trypanosome lysis.
Thomson R; Finkelstein A
Proc Natl Acad Sci U S A; 2015 Mar; 112(9):2894-9. PubMed ID: 25730870
[TBL] [Abstract][Full Text] [Related]
11. Mapping the membrane topography of the TH6-TH7 segment of the diphtheria toxin T-domain channel.
Kienker PK; Wu Z; Finkelstein A
J Gen Physiol; 2015 Feb; 145(2):107-25. PubMed ID: 25582482
[TBL] [Abstract][Full Text] [Related]
12. Pneumolysin activates macrophage lysosomal membrane permeabilization and executes apoptosis by distinct mechanisms without membrane pore formation.
Bewley MA; Naughton M; Preston J; Mitchell A; Holmes A; Marriott HM; Read RC; Mitchell TJ; Whyte MK; Dockrell DH
mBio; 2014 Oct; 5(5):e01710-14. PubMed ID: 25293758
[TBL] [Abstract][Full Text] [Related]
13. Channel-forming bacterial toxins in biosensing and macromolecule delivery.
Gurnev PA; Nestorovich EM
Toxins (Basel); 2014 Aug; 6(8):2483-540. PubMed ID: 25153255
[TBL] [Abstract][Full Text] [Related]
14. TcdA1 of Photorhabdus luminescens: electrophysiological analysis of pore formation and effector binding.
Lang AE; Konukiewitz J; Aktories K; Benz R
Biophys J; 2013 Jul; 105(2):376-84. PubMed ID: 23870259
[TBL] [Abstract][Full Text] [Related]
15. Obstructing toxin pathways by targeted pore blockage.
Nestorovich EM; Bezrukov SM
Chem Rev; 2012 Dec; 112(12):6388-430. PubMed ID: 23057504
[No Abstract] [Full Text] [Related]
16. Cellular internalisation of bacterial toxins.
Thelestam M
Cytotechnology; 1991 Feb; 5(Suppl 1):63-6. PubMed ID: 22358957
[No Abstract] [Full Text] [Related]
17. Mechanism of diphtheria toxin catalytic domain delivery to the eukaryotic cell cytosol and the cellular factors that directly participate in the process.
Murphy JR
Toxins (Basel); 2011 Mar; 3(3):294-308. PubMed ID: 22069710
[TBL] [Abstract][Full Text] [Related]
18. Toxin-based therapeutic approaches.
Shapira A; Benhar I
Toxins (Basel); 2010 Nov; 2(11):2519-83. PubMed ID: 22069564
[TBL] [Abstract][Full Text] [Related]
19. Membrane assembly of the cholesterol-dependent cytolysin pore complex.
Hotze EM; Tweten RK
Biochim Biophys Acta; 2012 Apr; 1818(4):1028-38. PubMed ID: 21835159
[TBL] [Abstract][Full Text] [Related]
20. The anthrax toxin channel: a barrel of LFs.
Blaustein RO
J Gen Physiol; 2011 Apr; 137(4):337-41. PubMed ID: 21402885
[No Abstract] [Full Text] [Related]
[Next] [New Search]
